63 results
8-K
EX-99.1
VRPX
Virpax Pharmaceuticals Inc
30 Apr 24
Other Events
7:35am
of a pharmaceutical-grade cannabidiol (CBD) for the management of rare pediatric epilepsy. Virpax has competitive cooperative research and development … and nonprescription drug candidates; the Company’s ability to maintain competitive cooperative research and development agreements (CRADAs) for its
8-K
EX-99.1
1rqm4uh9qje2n
26 Mar 24
Virpax Pharmaceuticals Reports 2023 Year-End Results
7:30am
8-K
EX-99.1
tce2w
1 Mar 24
Virpax Pharmaceuticals Announces Reverse Stock
4:05pm
8-K
EX-99.1
0iqj4kn
17 Nov 23
Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
7:30am
8-K
EX-99.1
1esb 2ygy
17 Nov 23
Virpax Pharmaceuticals Announces Leadership Transition
7:15am
8-K
EX-99.1
qeu0zv s9i
16 Nov 23
Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments
4:51pm
8-K
EX-99.1
8pzarawc9 xf85rr2wyi
5 Sep 23
Virpax Pharmaceuticals Updates on Litigation
9:28am
8-K
EX-99.1
10456
14 Aug 23
Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments
9:05am
DEFA14A
ogyyqdh4
22 Jun 23
Additional proxy soliciting materials
8:14am
8-K
EX-99.1
ght 18vx0fpr
21 Jun 23
Virpax Pharmaceuticals Announces CFO Transition
4:16pm
8-K
EX-99.1
0uyn01t smnsn44un4
12 May 23
Virpax Pharmaceuticals Reports 2023 First Quarter Results and Recent Developments
4:10pm